#1 Clinical Trials Search in Europe

Baclofen

Baclofen, a muscle relaxant and antispastic agent, has been the subject of numerous clinical trials investigating its potential benefits for various medical conditions. This article provides an overview of recent studies examining the use of baclofen in treating muscle cramps, spasticity, alcohol use disorder, and other conditions. We’ll explore the drug’s effectiveness, safety profile, and different administration methods being researched.

Table of Contents

What is Baclofen?

Baclofen is a medication that belongs to a class of drugs known as muscle relaxants and antispastic agents. It was first introduced in 1966 as a potential treatment for spasticity caused by injuries to the nervous system[1]. Baclofen is also known by several other names, including Gablofen, Lioresal, Apo-Baclofen, Dom-Baclofen, Liotec, Med-Baclofen, Mylan-Baclofen, Novo-Baclofen, Nu-Baclo, PHL-Baclofen, PMS-Baclofen, ratio-Baclofen, and Riva-Baclofen[1].

Medical Uses of Baclofen

Baclofen is used to treat various medical conditions, including:

  • Spasticity: This is a condition where muscles become stiff and difficult to control. Baclofen helps relax these muscles, making movement easier for patients with conditions like multiple sclerosis or spinal cord injuries[2][3].
  • Alcohol Use Disorder: Baclofen has shown promise in treating alcohol addiction by reducing cravings and helping patients maintain sobriety[4][5].
  • Muscle Cramps in Liver Cirrhosis: Patients with liver cirrhosis often experience painful muscle cramps. Baclofen has been studied as a potential treatment for these cramps[1].
  • Post-Traumatic Stress Disorder (PTSD): Some research is exploring whether baclofen can help prevent or reduce symptoms of PTSD in certain patient groups[6].

How Baclofen Works

Baclofen is a derivative of gamma-aminobutyric acid (GABA), a neurotransmitter that helps calm the nervous system. It works by activating GABA-B receptors in the brain and spinal cord[3]. This activation leads to:

  • Relaxation of tense and stiff muscles
  • Reduction in muscle spasms
  • Decreased transmission of certain sensory signals in the spinal cord

By influencing these processes, baclofen helps improve muscle function and reduce pain associated with spasticity[3].

Administration and Dosage

Baclofen can be administered in several ways:

  • Oral tablets: The most common form, usually taken multiple times a day[7].
  • Intrathecal injection: In some cases, baclofen may be delivered directly into the fluid surrounding the spinal cord through a surgically implanted pump[8].
  • Intravenous (IV) administration: This method is being studied for situations where oral baclofen needs to be temporarily replaced, such as when a patient can’t take oral medications[9].

The dosage of baclofen varies depending on the condition being treated, the patient’s response, and kidney function. It’s typically started at a low dose and gradually increased to find the most effective amount with the least side effects[5].

Potential Side Effects

Like all medications, baclofen can cause side effects. Some of the most commonly reported include:

  • Sedation or drowsiness: This is one of the most common side effects and may affect a person’s ability to drive or operate machinery[8].
  • Dizziness or lightheadedness
  • Weakness
  • Nausea
  • Confusion

In some cases, more serious side effects may occur, such as:

  • Seizures: Especially if the medication is stopped abruptly[9].
  • Hallucinations
  • Severe drowsiness or loss of consciousness

It’s important to report any unusual symptoms to your healthcare provider immediately[5].

Ongoing Research and Future Potential

Researchers continue to explore new potential uses for baclofen and ways to optimize its administration:

  • Alcohol Use Disorder: Studies are investigating whether baclofen can help reduce alcohol cravings and prevent relapse in people with alcohol addiction[4].
  • Post-Traumatic Stress Disorder (PTSD): Some research is looking at whether baclofen given during intensive care unit stays might help prevent PTSD in certain patients[6].
  • Growth Hormone Production: There’s interest in whether low-dose baclofen might help stimulate growth hormone production in people with spinal cord injuries[10].
  • Improved Administration Methods: Researchers are working on developing intravenous forms of baclofen for situations where oral medication isn’t possible[8].

These ongoing studies may lead to new approved uses for baclofen in the future, potentially helping even more patients with various conditions.

Aspect Details
Conditions Studied Muscle cramps in cirrhosis, spasticity in multiple sclerosis and spinal cord injuries, alcohol use disorder, baclofen withdrawal syndrome
Administration Methods Oral tablets, intravenous (IV) infusions, intrathecal administration via programmable pumps
Key Outcomes Measured Reduction in muscle cramps, spasticity levels, alcohol consumption patterns, adverse events, pharmacokinetics, bioequivalence of different forms
Safety Monitoring Sedation, ataxia, nystagmus, blood pressure changes, withdrawal syndrome, inflammatory granulomas (for intrathecal administration)
Special Populations Patients with liver cirrhosis, multiple sclerosis, spinal cord injuries, alcohol use disorder
Novel Applications Effects on growth hormone and IGF-1 levels in spinal cord injury patients

FAQ

  • What conditions is baclofen being studied for in clinical trials? Baclofen is being studied for a variety of conditions, including muscle cramps in patients with liver cirrhosis, spasticity in multiple sclerosis and spinal cord injuries, alcohol use disorder, and baclofen withdrawal syndrome. It's also being investigated for its effects on growth hormone levels in spinal cord injury patients.
  • How is baclofen administered in these trials? Baclofen is being administered in various forms across different trials. These include oral tablets, intravenous (IV) infusions, and intrathecal administration using programmable pumps. Some studies are comparing the effectiveness and safety of different administration routes.
  • What are some potential side effects of baclofen being monitored in these trials? Researchers are monitoring for side effects such as sedation, ataxia (loss of muscle coordination), nystagmus (involuntary eye movement), and changes in blood pressure. Some studies are also investigating the potential for baclofen withdrawal syndrome and the formation of inflammatory granulomas with intrathecal administration.
  • Are there any studies looking at baclofen's effect on alcohol use disorder? Yes, there is a study called BACLOPHONE that is monitoring patients prescribed baclofen for alcohol use disorder. This study aims to determine the rate of treatment discontinuation due to adverse events and to better understand the types of adverse events associated with baclofen use in this context.
  • How are researchers assessing the effectiveness of baclofen in these trials? Researchers are using various measures to assess baclofen's effectiveness, depending on the condition being studied. These include monitoring changes in muscle cramp frequency, spasticity levels, alcohol consumption patterns, and biomarkers such as growth hormone and IGF-1 levels. Some studies are also looking at patient preference and quality of life measures.

Ongoing Clinical Trials on Baclofen

  • Study on Baclofen for Reducing Benzodiazepine Use in Patients with Benzodiazepine Dependence

    Recruiting

    1 1 1
    Investigated drugs:
    France

  • Study on Baclofen for Inpatient Detoxification in Patients with GHB Use Disorder

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Comparison of intrathecal baclofen pump and selective dorsal rhizotomy for children with cerebral palsy who cannot walk

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium The Netherlands

  • Comparison of Pregabalin and Baclofen Treatment in Patients with Spastic Motor Behavior Following Cervical or Thoracic Spinal Cord Injury

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

  • Study on Baclofen for Inpatient Detoxification in Patients with GHB Use Disorder

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Baclofen for Pulmonary and Sleep Disorders in Spinal Cord Injury Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Baclofen: A muscle relaxant and antispastic agent that is a derivative of gamma-aminobutyric acid (GABA). It's used to treat muscle spasms and is being studied for various other conditions.
  • Spasticity: A condition in which certain muscles are continuously contracted, causing stiffness or tightness that can interfere with normal movement and speech.
  • Intrathecal: Referring to the space under the arachnoid membrane of the brain or spinal cord. In some studies, baclofen is administered intrathecally using a programmable pump.
  • Bioequivalence: The property of two drug products having the same biological effect in the body. Some studies are comparing the bioequivalence of different forms of baclofen administration.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion. Several trials are examining the pharmacokinetics of baclofen.
  • Adverse Event (AE): Any unfavorable and unintended sign, symptom, or disease temporarily associated with the use of a medical treatment or procedure.
  • Cirrhosis: A late stage of scarring (fibrosis) of the liver caused by many forms of liver diseases and conditions. One study is examining baclofen's effect on muscle cramps in cirrhosis patients.
  • Ataxia: A lack of muscle coordination which may affect speech, eye movements, the ability to swallow, walking, picking up objects, and other voluntary movements.
  • Nystagmus: A condition characterized by involuntary eye movement, which can result in reduced or limited vision.
  • IGF-1 (Insulin-like Growth Factor 1): A hormone similar in molecular structure to insulin, playing an important role in childhood growth and continuing to have anabolic effects in adults.

References

  1. https://clinicaltrials.gov/study/NCT02221570
  2. https://clinicaltrials.gov/study/NCT00139789
  3. https://clinicaltrials.gov/study/NCT04471714
  4. https://clinicaltrials.gov/study/NCT02723383
  5. https://clinicaltrials.gov/study/NCT02596763
  6. https://clinicaltrials.gov/study/NCT05877807
  7. https://clinicaltrials.gov/study/NCT00647738
  8. https://clinicaltrials.gov/study/NCT02760992
  9. https://clinicaltrials.gov/study/NCT01749319
  10. https://clinicaltrials.gov/study/NCT00871455